drug
cobimetinib fumarate
Marketedupdated 5mo agoby Genentech Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 5, 2027
178 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (13)
- Dec 30, 2036patentUS 10590102*PED
- Dec 30, 2036patentUS 11254649*PED
- Dec 29, 2036patentUS 10478400*PED
- Jun 30, 2036compositionUS 10590102
- Jun 30, 2036compositionUS 11254649
- Jun 29, 2036compositionUS 10478400
- Dec 22, 2034patentUS 11087354*PED
- Jun 22, 2034method-of-use (U-1776)US 11087354
- May 10, 2030patentUS 7803839*PED3.6y
- Nov 10, 2029compositionUS 78038393.1y
- Apr 5, 2027patentUS 8362002*PED178d
- Oct 5, 2026method-of-use (U-3554)US 11597699
- Oct 5, 2026method-of-use (U-1776)US 8362002
FDA exclusivities (3)
- Oct 28, 2029ODE-416Orphan Drug (7y)3.1y
- Jan 28, 2026PEDPediatric (6mo bonus)
- Jul 28, 2025M-278Method (3y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 47m ago
Found something off?
comments(0)
5-min edit window · permanent after that